“Assuming the talk is correct, it is hard to see the device proving immediately attractive to the mass market given a price expected somewhere between $500 and $900,” Peers writes.
“Of course, it is dangerous betting against Steve Jobs. Apple could cut the device’s price,” Peers hedges.
“While it is good news that Apple is still innovating, investors shouldn’t expect any near-term bottom-line benefit from the tablet,” Peers opines. “The iPhone will remain the growth engine for the company for a while yet. Buying shares on enthusiasm about the tablet is putting the apple cart before the horse.”
Full article here.
MacDailyNews Take: Again: Blind prognostication is the practice of idiots.